Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders
- PMID: 18818027
- PMCID: PMC2758688
- DOI: 10.1016/j.drugalcdep.2008.07.016
Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders
Abstract
Objectives: To assess the clinical characteristics of adolescents with DSM-IV opioid use disorder (OUD) and compare them to adolescents with cannabis/alcohol use disorders.
Method: 94 adolescents (ages 14-18 years) with a current OUD and 74 adolescents with a current non-OUD cannabis/alcohol use disorders were recruited from admissions, predominantly residential, to a substance abuse treatment program in Baltimore, ML. Participants were assessed cross-sectionally using standardized interviews and self-reports. Chi-square, t-tests and ANCOVA (adjusting for age, gender and treatment setting, race and residence) were performed to determine group differences on demographic, substance use, psychiatric and HIV-risk behaviors; logistic regression analyses, both unadjusted and adjusted for the above five factors were conducted to assess the strength of associations.
Results: The OUD group was more likely to be Caucasian, to have dropped out of school and to live in the suburbs (trend). They also had greater substance use severity with higher proportion of current sedative and multiple substance use disorders (SUD). There were generally no differences in rates of criminal behaviors. Both groups had high rates of current psychiatric disorders (83% vs. 78%, n.s.) but the OUD adolescents reported higher depressive symptoms, mostly in the moderate range. Injection drug use (IDU) and needle sharing was almost exclusive to the OUD group, while both groups reported similar high rates of risky sexual behaviors.
Conclusions: While there were similarities between the two groups, OUD adolescents evidenced greater impairment in academic, substance use, depressive symptom and IDU-related HIV-risk areas. Findings suggest poorer long-term prognosis and highlight the need for specialized interventions for treatment-seeking OUD adolescents.
References
-
- Beck A, Steer R, Gabin M. Psychometric properties of the BDI: Twenty-five years of evaluation. Clinical Psychological Review. 1998;8:77–100.
-
- Brooner RK, King VL, Kidorf M, Schmidt CW, Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71–80. - PubMed
-
- Bukstein OG, Glancy LJ, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1992;31:1041–1045. - PubMed
-
- Catalano RF, Hawkins JD, Wells EA, Miller J, Brewer D. Evaluation of the effectiveness of adolescent drug abuse treatment, assessment of risks for relapse, and promising approaches for relapse prevention. Int J Addict. 1990;25:1085–1140. - PubMed
-
- Center for Disease Control and Prevention (CDC) Viral Hepatitis and injection drug users. 2002. Sep [Accessed on September 19, 2007]. http://www.cdc.gov/IDU/hepatitis/viral_hep_drug_use.htm.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous